Munich - Delayed Quote EUR
ChromaDex Corp (OCD1.MU)
6.20
+0.20
+(3.33%)
As of 8:08:08 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
12,109
12,109
7,117
-15,098
-24,163
Investing Cash Flow
-143
-143
-143
-334
-409
Financing Cash Flow
5,369
5,369
-90
7,654
36,094
End Cash Position
44,660
44,660
27,325
20,441
28,219
Interest Paid Supplemental Data
1
1
2
1
1
Capital Expenditure
-163
-163
-148
-334
-409
Issuance of Capital Stock
--
--
--
7,747
26,740
Repayment of Debt
-11
-11
-15
-16
-31
Free Cash Flow
11,946
11,946
6,969
-15,432
-24,572
12/31/2021 - 3/18/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BT3.BE Lineage Cell Therapeutics Inc
0.4020
+8.06%
HTD.MU Corcept Therapeutics Inc
60.20
+5.73%
HQ1.MU Oruka Therapeutics Inc. R
9.15
+0.55%
NXOA.BE Nicox SA
0.2260
0.00%
0M4.DU Mersana Therapeutics Inc
0.3383
+0.06%
RASP Actavia Life Sciences, Inc.
0.0040
0.00%
GON.DU Geron Corp
1.2350
+0.90%
300759.SZ Pharmaron Beijing Co., Ltd.
23.08
+1.58%
50BA.F Bicycle Therapeutics plc
6.75
-11.18%
PI3.DU Gubra AS
46.80
-2.94%